Paulo Castaneda1,2, Alex McLaren3,4,5,6, Gamuchirai Tavaziva6, Derek Overstreet5,6. 1. Banner - University Medical Center Phoenix, 1320 N 10th Street, Phoenix, AZ, 85006, USA. pcastan6@gmail.com. 2. Center for Interventional Biomaterials, Arizona State University, Tempe, AZ, USA. pcastan6@gmail.com. 3. Banner - University Medical Center Phoenix, 1320 N 10th Street, Phoenix, AZ, 85006, USA. 4. College of Medicine-Phoenix, University of Arizona, Phoenix, AZ, USA. 5. Sonoran Biosciences, Chandler, AZ, USA. 6. Center for Interventional Biomaterials, Arizona State University, Tempe, AZ, USA.
Abstract
BACKGROUND: The antimicrobial concentration required to kill all the bacteria in a biofilm, known as the minimum biofilm eradication concentration (MBEC), is typically determined in vitro by exposing the biofilm to serial concentrations of antimicrobials for 24 hours or less. Local delivery is expected to cause high local levels for longer than 24 hours. It is unknown if longer antimicrobial exposures require the same concentration to eradicate bacteria in biofilm. Questions/purposes Does MBEC change with increased antimicrobial exposure time? METHODS: Biofilms were grown for 24 hours using five pathogens (methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa) and then exposed to four antimicrobials regimens: tobramycin, vancomycin, and tobramycin combined with vancomycin in 3:1 and 1:1 ratios by weight in concentrations of 62.5, 125, 250, 500, 1000, 2000, 4000, and 8000 μg/mL for three durations, 1, 3, and 5 days, in triplicate. MBEC was measured as the lowest concentration that killed all bacteria in the biofilm determined by 21-day subculture. RESULTS: MBEC was lower when antimicrobial exposure time was longer. For the staphylococcus species, the MBEC was lower when exposure time was 5 days than 1 day in 11 of 12 antimicrobial/microorganism pairs. The MBEC range for these 11 pairs on Day 1 was 4000 to > 8000 μg/mL and on Day 5 was < 250 to 8000 μg/mL. MBEC for tobramycin/P. aeruginosa was 2000 μg/mL on Day 1 and ≤ 250 μg/mL on Day 5, and for E. coli, 125 μg/mL on Day 1 and ≤ 62.5 on Day 5. CONCLUSIONS: Although antimicrobial susceptibility was lower for longer exposure times in the microorganisms we studied, confirmation is required for other pathogens. Clinical Relevance One-day MBEC assays may overestimate the local antimicrobial levels needed to kill organisms in biofilm if local levels are sustained at MBEC or above for longer than 24 hours. Future studies are needed to confirm that antimicrobial levels achieved clinically from local delivery are above the MBEC at relevant time points and to confirm that MBEC for in vitro microorganisms accurately represents MBEC of in vivo organisms in an clinical infection.
BACKGROUND: The antimicrobial concentration required to kill all the bacteria in a biofilm, known as the minimum biofilm eradication concentration (MBEC), is typically determined in vitro by exposing the biofilm to serial concentrations of antimicrobials for 24 hours or less. Local delivery is expected to cause high local levels for longer than 24 hours. It is unknown if longer antimicrobial exposures require the same concentration to eradicate bacteria in biofilm. Questions/purposes Does MBEC change with increased antimicrobial exposure time? METHODS: Biofilms were grown for 24 hours using five pathogens (methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa) and then exposed to four antimicrobials regimens: tobramycin, vancomycin, and tobramycin combined with vancomycin in 3:1 and 1:1 ratios by weight in concentrations of 62.5, 125, 250, 500, 1000, 2000, 4000, and 8000 μg/mL for three durations, 1, 3, and 5 days, in triplicate. MBEC was measured as the lowest concentration that killed all bacteria in the biofilm determined by 21-day subculture. RESULTS: MBEC was lower when antimicrobial exposure time was longer. For the staphylococcus species, the MBEC was lower when exposure time was 5 days than 1 day in 11 of 12 antimicrobial/microorganism pairs. The MBEC range for these 11 pairs on Day 1 was 4000 to > 8000 μg/mL and on Day 5 was < 250 to 8000 μg/mL. MBEC for tobramycin/P. aeruginosa was 2000 μg/mL on Day 1 and ≤ 250 μg/mL on Day 5, and for E. coli, 125 μg/mL on Day 1 and ≤ 62.5 on Day 5. CONCLUSIONS: Although antimicrobial susceptibility was lower for longer exposure times in the microorganisms we studied, confirmation is required for other pathogens. Clinical Relevance One-day MBEC assays may overestimate the local antimicrobial levels needed to kill organisms in biofilm if local levels are sustained at MBEC or above for longer than 24 hours. Future studies are needed to confirm that antimicrobial levels achieved clinically from local delivery are above the MBEC at relevant time points and to confirm that MBEC for in vitro microorganisms accurately represents MBEC of in vivo organisms in an clinical infection.
Authors: Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers Journal: Clin Infect Dis Date: 2011-01-04 Impact factor: 9.079
Authors: Steven L Percival; Dieter Mayer; Robert S Kirsner; Greg Schultz; Dot Weir; Sashwati Roy; Afsaneh Alavi; Marco Romanelli Journal: Int Wound J Date: 2019-03-18 Impact factor: 3.315
Authors: Derek J Overstreet; Vajra S Badha; John M Heffernan; Erin P Childers; Rex C Moore; Brent L Vernon; Alex C McLaren Journal: Drug Deliv Transl Res Date: 2019-08 Impact factor: 4.617
Authors: Matthew Malone; Saskia Schwarzer; Michael Radzieta; Thomas Jeffries; Annie Walsh; Hugh G Dickson; Grace Micali; Slade O Jensen Journal: Int Wound J Date: 2019-09-05 Impact factor: 3.315
Authors: Hyun Koo; Raymond N Allan; Robert P Howlin; Paul Stoodley; Luanne Hall-Stoodley Journal: Nat Rev Microbiol Date: 2017-09-25 Impact factor: 60.633
Authors: Jonathan B Mandell; Sara Orr; John Koch; Blake Nourie; Dongzhu Ma; Daniel D Bonar; Neel Shah; Kenneth L Urish Journal: J Orthop Res Date: 2019-04-08 Impact factor: 3.494
Authors: Edward M Schwarz; Alex C McLaren; Thomas P Sculco; Barry Brause; Mathias Bostrom; Stephen L Kates; Javad Parvizi; Volker Alt; William V Arnold; Alberto Carli; Antonia F Chen; Hyonmin Choe; Débora C Coraça-Huber; Michael Cross; Michelle Ghert; Noreen Hickok; Jessica Amber Jennings; Manjari Joshi; Willem-Jan Metsemakers; Mark Ninomiya; Kohei Nishitani; Irvin Oh; Douglas Padgett; Benjamin Ricciardi; Kordo Saeed; Parham Sendi; Bryan Springer; Paul Stoodley; Joseph C Wenke Journal: J Orthop Res Date: 2020-03-02 Impact factor: 3.102
Authors: Christian Schütz; Duy-Khiet Ho; Mostafa Mohamed Hamed; Ahmed Saad Abdelsamie; Teresa Röhrig; Christian Herr; Andreas Martin Kany; Katharina Rox; Stefan Schmelz; Lorenz Siebenbürger; Marius Wirth; Carsten Börger; Samir Yahiaoui; Robert Bals; Andrea Scrima; Wulf Blankenfeldt; Justus Constantin Horstmann; Rebekka Christmann; Xabier Murgia; Marcus Koch; Aylin Berwanger; Brigitta Loretz; Anna Katharina Herta Hirsch; Rolf Wolfgang Hartmann; Claus-Michael Lehr; Martin Empting Journal: Adv Sci (Weinh) Date: 2021-03-18 Impact factor: 16.806